SelenBio, Inc is a biotechnology company specializing in the prevention of bacterial biofilm formation for dental, healthcare, industrial, and consumer applications. Our proprietary SELDOXŽ antimicrobial technology is able to inhibit bacterial biofilm formation and attachment on surfaces through a covalently linked, catalytic, and safe compound that does not leach into the surrounding environment. These properties allow for effective, safe, and low cost protection against bacteria and biofilm for the duration of the useful life of the substrate. SelenBio partners with companies seeking to enhance their product effectiveness through antimicrobial protection and biofilm control. Source
No articles found.
GENFIT is a late-stage biopharmaceutical company dedicated to the discovery and de...
GENFIT is a late-stage biopharmaceutical compan...
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focus...
Incyte Corporation is a Wilmington, Delaware-ba...
Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the develo...
Puma Biotechnology, Inc. is a biopharmaceutical...
Genomic Health, Inc. (NASDAQ: GHDX) is the world's leading provider of genomic-bas...
Genomic Health, Inc. (NASDAQ: GHDX) is the worl...
Join the National Investor Network and get the latest information with your interests in mind.